Page last updated: 2024-08-23

phosphotyrosine and Laryngeal Neoplasms

phosphotyrosine has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Steinberg, BM; Sun, S	1

Other Studies

1 other study(ies) available for phosphotyrosine and Laryngeal Neoplasms

Article	Year
PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. The Journal of general virology, 2002, Volume: 83, Issue:Pt 7 Topics: Cell Extracts; DNA-Binding Proteins; DNA, Complementary; Down-Regulation; Epithelium; Genes, Tumor Suppressor; HeLa Cells; Humans; Laryngeal Neoplasms; Larynx; Mutation; Papilloma; Papillomaviridae; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphotransferases; Phosphotyrosine; PTEN Phosphohydrolase; STAT3 Transcription Factor; Trans-Activators; Transfection; Tumor Cells, Cultured; Tumor Suppressor Proteins	2002

Article

Year

PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells.

The Journal of general virology, 2002, Volume: 83, Issue:Pt 7

Topics: Cell Extracts; DNA-Binding Proteins; DNA, Complementary; Down-Regulation; Epithelium; Genes, Tumor Suppressor; HeLa Cells; Humans; Laryngeal Neoplasms; Larynx; Mutation; Papilloma; Papillomaviridae; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphotransferases; Phosphotyrosine; PTEN Phosphohydrolase; STAT3 Transcription Factor; Trans-Activators; Transfection; Tumor Cells, Cultured; Tumor Suppressor Proteins

2002